![Emily Anne Scraggs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emily Anne Scraggs
Director/Miembro de la Junta en Talisman Therapeutics Ltd. .
Perfil
Emily Anne Scraggs is the founder of Gen2 Neuroscience Ltd., which was founded in 2016.
She held the title of Director at the company.
Currently, she is a Director & Commercial Director at Talisman Therapeutics Ltd.
Cargos activos de Emily Anne Scraggs
Empresas | Cargo | Inicio |
---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Emily Anne Scraggs.
Empresas | Cargo | Fin |
---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Emily Anne Scraggs